Dave Helsel - Oct 20, 2021 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role: SVP Global Operations and R&D
Signature: /s/ Richard C. Rosenzweig, Attorney in Fact
Stock symbol: ANGO
Transactions as of: Oct 20, 2021
Transactions value $: -$97,727
Form type: 4
Date filed: 10/21/2021, 04:50 PM
Previous filing: Aug 18, 2021
Next filing: May 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANGO	Common Stock	Sale	-$97.7K	-3.49K	-11.69%	$27.97	26.4K	Oct 20, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.95 to $28.05, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.95 to $28.05, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.